AcuCort operates within medical technology. The company develops fast-dissolving oral films with specific chemical substances that are used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. The products can be used by both children and adults. The main part of the business is within the Nordic markets. AcuCort was founded in 2006 and is based in Helsingborg.

Quotes for AcuCort AB

Right Now

+/-
-0.01
%
-0,32%
Latest
3.13
High
3.14
Low
2.95
Volume
2 312
Turnover (SEK)
6 912
Value (MSEK)
61,3

Board

CEO

  • Ann Gidner (tf)

Chairman Of The Board

  • Ebba Fåhraeus

Board

  • Alexandra Johnsson
  • Anna Eriksrud
  • Göran Kvist
  • Lennart Bruce

Videos

Upcoming reports

  • 2020-08-28 Delårsrapport 2020-Q2

  • 2020-11-13 Delårsrapport 2020-Q3

  • 2021-02-18 Bokslutskommuniké 2020